Department of Cardiac Surgery & Department of Thoracic Surgery
About the unit
The Cardiothoracic unit at the Glenfield Hospital is part of the University Hospitals of Leicester NHS Trust. It serves a population of 1.9 million and is a secondary and tertiary referral centre for adult and paediatric acquired and congenital heart disease. It has one of the world’s largest ECMO programmes which works in collaboration with the cardiac surgical unit.
Adult Cardiac Surgery
Congenital Cardiac Surgery
Rehabilitation and follow up
Follow up is generally 6 weeks to the appropriate surgeon with a discharge back to the GP as required. Cardiac rehabilitation is provided locally for catchment patients or if from an adjacent area the appropriate contact is made with the local hospital's rehab team to ensure continuity of care. We have a web site for patients who do not live locally to access an on-line rehabilitation programme that the patient can undertake themselves at home.
Access to the wards is through either the main entrance or the south entrance. Cars are allowed to drop patients off close to the entrance doors prior to parking in the adjacent car park. There is wheelchair access, doors are electronically operated.
Ward visiting is 09.00 – 12.00 and 15.00 – 20.00 hrs with a quiet time between 13.00 – 15.00 hrs. There are no fixed visiting times for the cardiac intensive care unit.
Department of Cardiothoracic Surgery,
Tel: 0116 287 1471
Trust website: http://www.leicestershospitals.nhs.uk/
Risk adjusted in-hospital survival rate
This graph shows the “in hospital” survival rate of patients who are operated on by the individual surgeon/unit you have selected. “In hospital” means time the patient is in the hospital where they have had their operation. It does not include any time that patients may have spent in other hospitals, either before or after their heart operation.
The data has been through a complex methodology, including the variations in patient risk factors in order to give you a comparative base from which to work from. This means that the survival rates take into account the type and risk of patients being operated on for each surgeon/unit. This is known as risk adjusted survival.
The vertical axis shows the GMC number of the surgeon or the Hospital identifier. In brackets is the total number of patients operated on by the surgeon/unit and the percentage of patients for whom the survival is known. The horizontal axis is the percentage survival. The dashed vertical line shows the risk adjusted survival rate for the UK as a whole. The solid black horizontal line represents the surgeon/unit. What is important here is that the horizontal line crosses the vertical dashed line. If this occurs, it means that the surgeon/unit are within the expected outcomes given the case-mix and risk factors of the patients they operate on.
The icons that sit on the horizontal line should give you more information about your surgeon/team.
The open square is the survival rate with no risk adjustments:
The X is the predicted survival with adjustments
The solid dot is the survival probability after the methodology has been applied.
- If the solid dot is red it means survival is worse than expected
- If the solid dot is black it means that it is within limits
- If the solid dot is green it means that there is significantly higher survival than expected
There is a lot of information on these plots, but the takeaway message is that if the solid black line crosses the dashed vertical line then the survival rate for the surgeon/unit is within expectations and that there is no reason for any concern.
A more detailed explanation about these graphs and methodology can be found here: Graph Explanations
Data for period April 2015 – March 2018.
Risk Adjusted In-Hospital Survival Rate
Data For Period April 2015 – March 2018
Risk Adjusted In-Hospital Survival Rate
The Lung Cancer Clinical Outcomes Publication or LCCOP 2017 (2015 data).
LCCOP is a compulsory audit of surgery for lung cancer in NHS hospitals in England. It does not cover SCTS units in the devolved nations or Ireland.
Four outcomes are reported. These are the percentage of patients alive at 30, 90 days and one year after surgery, and the median length of stay before and after a lung cancer operation in this Trust. Survival data are adjusted to take into account some of the characteristics for the patient population being treated.
Beside these numbers are the combined figures for all Trusts in England that undertake lung cancer surgery within the NHS. We have also shown the resection rates for the Trusts who usually referred all or some of their patients to this surgical centre. The resection rate is the number of patients having lung cancer surgery, divided by the total number of lung cancer patients diagnosed by that hospital that year.
Surgeons operating in this hospital
|Number of lung cancer operations|
|Waller David Andrew||80|
Other thoracic surgery undertaken by this team
Thoracic surgery units also undertake surgery for other cancers within the chest such as thymoma or mesothelioma, collapsed lungs known as pneumothorax, major infections and to biopsy suspicious areas, among other surgery. The SCTS collects data on these other operations in the thoracic registry. Some data for this hospital for the 2016-17 audit year* is given below;
Data from the 2016-17 SCTS thoracic registry
|Total thoracic surgery excluding endoscopy all case (excluding endoscopy)||863|
|Did this hospital perform radical surgery for mesothelioma in 2015-16?||yes|
|Did this hospital perform chest wall deformity (pectus) surgery in 2015-16?||yes|
*note that the thoracic registry reports in financial years (1st April-31st March), while the LCCOP audit reports in calendar year.
Consultant Cardiac Surgeons 2015 - 2018: 9
- Bitay Miklos
- Efthymiou Christopher
- Hadjinikolaou Leonidas
- Hickey Mark
- Mariscalco Giovanni
- Murphy Gavin
- Szostek Jacek
- Vohra Hunaid
- Zlocha Viktor
Consultant Congenital Cardiothoracic Surgeons: 0
Consultant Thoracic Surgeons 2014: 5